Table 1.
N studies | N vHL | Frequency (%, 95% CI) | Q Cochran P value | I² | |
---|---|---|---|---|---|
Participants with vHL (all vHL types) | |||||
Frequency of participants with PPGL | 45 | 4263 | 19.4 (15.9–23.6) | <0.001 | 86.1% |
Participants with bilateral pheochromocytoma | 14 | 59.5 (47.0–70.9) | 0.611 | 0% | |
Males with PPGL | 15 | 58.3 (47.6–68.4) | 0.837 | 0% | |
Participants with vHL type 2 | 840 | ||||
Frequency of participants with PPGL | 52 | 60.0 (53.4–66.3) | <0.001 | 54.6% | |
Participants with PPGL in vHL type 2A | 28 | 411 | 58.2 (49.7–66.3) | 0.010 | 36.2% |
Participants with PPGL in vHL type 2B | 24 | 256 | 49.8 (39.9–59.7) | 0.013 | 42.7% |
Participants with PPGL in vHL type 2C | 11 | 52 | 84.1 (75.1–93.1) | 0.932 | 0% |